Lutropin Alfa News
Lutropin Alfa currently has 0 news articles, with 20 predicted indications.
This page combines the AI-predicted indications for Lutropin Alfa with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Original indication: Luveris in association with a follicle-stimulating-hormone (FSH) preparation is recommended for the stimulation of follicular development in women with severe luteinising-hormone (LH) and FSH...
- Evidence level: L5
- Predicted indications (20):
- postural orthostatic tachycardia syndrome (97.0%)
- peptic esophagitis (97.0%)
- trichotillomania (96.3%)
- Raynaud disease (95.7%)
- duodenal ulcer (disease) (95.6%)
- Tourette syndrome (95.2%)
- esophageal disease (94.9%)
- sinoatrial block (94.9%)
- multiple endocrine neoplasia (94.9%)
- duodenogastric reflux (94.6%)
- duodenal obstruction (94.4%)
- sinoatrial node disease (94.2%)
- non-syndromic esophageal malformation (93.5%)
- amenorrhea (disease) (93.1%)
- active peptic ulcer disease (92.8%)
- esophageal ulcer (92.7%)
- progressive familial heart block (92.6%)
- adrenal gland hyperfunction (92.4%)
- gastrojejunal ulcer (92.4%)
- peptic ulcer perforation (92.4%)
Related News (0)
No related news yet. When news mentions this drug, it will be collected and shown here automatically.
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.